November 16, 2023

CF Foundation Invests in Novel Genetic Therapy Delivery Mechanism

As part of our Path to a Cure research initiative to accelerate treatments for all people with cystic fibrosis, we’re investing up to $3 million in ViaNautis, which is developing a technology to address key challenges in genetic delivery.

Read more »

A light-skinned man wearing a lab coat and latex gloves works at a fume hood.

Save the Date for GivingTuesday 

GivingTuesday is less than two weeks away, and we have some exciting news to share! On Tuesday, November 28, your gift will be matched, dollar-for-dollar, up to $250,000, thanks to the generosity of Lou and Nancy Stremick, whose 18-year-old granddaughter, Ella, has cystic fibrosis. Save the date and help us make this GivingTuesday our biggest yet! 

Save the date »

Have Thoughts on CF Care? 

Living with CF can be very different for many people. Take the Adapting CF Care survey to share your thoughts on how CF Foundation care centers can better meet your or your loved ones’ needs. The survey, which takes 6 to 11 minutes, is available until December 20. Highlights from survey results will be shared in early 2024. 

Take the survey »

A light-skinned woman wearing a medical face mask sits and holds a binder of papers and a light-skinned woman wearing a medical face mask sits with a school-aged girl wearing a medical face mask in her lap.

CF Foundation External Racial Justice Working Group Formalizes Final Recommendations

As part of the CF Foundation’s ongoing commitment to advance equity, racial justice, diversity, and inclusion, the External Racial Justice Working Group has finalized recommendations to help guide our work to foster a more inclusive community. Previous recommendations were formalized in the focus areas of health equity and outcomes and diverse workforce development.

Read the recommendations »

www.cff.org

DONATE

4550 Montgomery Avenue, Suite 1100N | Bethesda, MD 20814 US

Opt out of this mailing list

Opt out out of all CF Foundation emails

This email was sent to [email protected]

Got this as a forward? Sign up to receive our future emails.